Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001647488-15-000117
Filing Date
2015-09-25
Accepted
2015-09-25 15:41:40
Documents
10
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 MAINBODY mainbody.htm 10-Q 474086
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 8625
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 8625
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 3913
  Complete submission text file 0001647488-15-000117.txt   3623217

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE rcha-20150630.xml EX-101.INS 728559
6 XBRL SCHEMA FILE rcha-20150630.xsd EX-101.SCH 51688
7 XBRL CALCULATION FILE rcha-20150630_cal.xml EX-101.CAL 28737
8 XBRL DEFINITION FILE rcha-20150630_def.xml EX-101.DEF 135598
9 XBRL LABEL FILE rcha-20150630_lab.xml EX-101.LAB 232020
10 XBRL PRESENTATION FILE rcha-20150630_pre.xml EX-101.PRE 213804
Mailing Address 9595 WILSHIRE BLVD., SUITE 900 BEVERLY HILLS CA 90212
Business Address 9595 WILSHIRE BLVD., SUITE 900 BEVERLY HILLS CA 90212 (424) 230-7001
Rich Pharmaceuticals, Inc. (Filer) CIK: 0001504389 (see all company filings)

EIN.: 463259117 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-54767 | Film No.: 151125182
SIC: 2834 Pharmaceutical Preparations